指南与共识妇产影像泌尿生殖USMR

附件囊肿及囊性肿物的风险分层:放射科医师协会超声指南的临床效能

Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound Guidelines.
指南 / 共识 · Radiology · 2017-07-20

本回顾性研究纳入2011年1至6月经超声检出且有手术诊断或至少2年随访的附件囊肿570个(500例女性,18-90岁),评估2010年SRU共识指南的风险分层效能。按SRU推荐评分0-3分,肿瘤及恶性肿瘤比例随评分升高而增加(趋势P<.0001);若指南允许时选择MR成像,可减少82个(89.1%)良性囊肿直接手术评估。SRU指南有效分层肿瘤和恶性肿瘤风险。

要点

  • SRU评分0-3分与肿瘤风险呈显著趋势(P<.0001),评分越高肿瘤比例越高。
  • 按「手术为主」解读时,SRU 3分恶性肿瘤占16%;按「MR可用」解读时SRU 3分恶性肿瘤占52%。
  • 指南允许时选择MR随访可减少82个(89.1%)良性囊肿直接手术评估。

核心结论

  • SRU共识指南有效分层了附件囊肿的肿瘤和恶性肿瘤风险。
  • 在指南允许时选择MR成像可减少良性囊肿直接手术评估的数量。

研究设计与样本

  • 经机构审查委员会批准的回顾性研究,纳入2011年1月至6月超声检出附件囊肿且有手术诊断或至少2年影像或临床随访的病例。
  • 共570个囊肿(500例女性,年龄18-90岁,平均42岁),其中无症状女性161例(32.2%)。
  • SRU管理推荐评分:0分无随访,1分超声随访,2分MR随访,3分手术评估;指南允许多种管理选项时按「手术为主」或「MR可用」两种环境解读。
  • 采用Cochran-Armitage趋势检验比较各评分组结局分布,多变量logistic回归评估肿瘤和恶性肿瘤预测因素。

诊断标准与关键数值

  • 按「手术为主」解读:SRU 0分肿瘤1%、恶性0%;SRU 1分肿瘤17%、恶性1%;SRU 2分肿瘤48%、恶性0%;SRU 3分肿瘤48%、恶性16%(趋势P<.0001)。
  • 按「MR可用」解读:SRU 0分肿瘤1%、恶性0%;SRU 1分肿瘤17%、恶性1%;SRU 2分肿瘤38%、恶性5%;SRU 3分肿瘤81%、恶性52%(趋势P<.0001)。
  • 多变量回归中SRU评分预测任何肿瘤(OR 2.58,P<.0001)和恶性肿瘤(OR 4.94,P=.005)。

临床应用与阅片要点

  • SRU评分可用于附件囊肿风险分层,评分越高肿瘤和恶性肿瘤比例越高。
  • 按「MR可用」解读指南时,SRU 3分恶性肿瘤比例(52%)高于「手术为主」解读(16%)。
  • 指南允许时选择MR成像可使82个(89.1%)良性囊肿避免直接手术评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the performance of the 2010 Society of Radiologists in Ultrasound (SRU) consensus guidelines in the risk stratification of symptomatic and asymptomatic adnexal cysts. Materials and Methods An institutional review board-approved retrospective review was performed, including adnexal cysts detected with ultrasonography (US) with surgical diagnosis or at least 2 years of imaging or clinical follow-up, from January to June 2011. SRU management recommendations were scored as 0, no follow-up; 1, US follow-up; 2, magnetic resonance (MR) imaging follow-up; and 3, surgical evaluation. Distribution of outcomes (nonneoplastic cyst, benign neoplasm, malignant neoplasm) was compared in each rating group by using the Cochran-Armitage trend test. Where SRU guidelines allow more than one management option, they were classified as being interpreted in either a "surgically focused" environment, with limited MR imaging availability, or an "MR-capable" center, where MR imaging is selected whenever it is an option. Predictors of neoplasms and malignancy were evaluated by using multivariate logistic regression. Results A total of 570 cysts in 500 women aged 18-90 years (mean, 42 years) were included. There were 475 (83.3%) nonneoplastic cysts, 77 (13.5%) benign neoplasms, and 18 (3.2%) malignant neoplasms. Of the 500 women, 161 (32.2%) were asymptomatic. In the surgically focused interpretation of guidelines, proportions of any neoplasm and malignant neoplasm, respectively, were 1% and 0% in SRU 0, 17% and 1% in SRU 1, 48% and 0% in SRU 2, and 48% and 16% in SRU 3 (P < .0001 for both trends). In the interpretation of SRU guidelines with MR imaging when it was an option, proportions of any neoplasm and malignant neoplasm, respectively, were 1% and 0% in SRU 0, 17% and 1% in SRU 1, 38% and 5% in SRU 2, and 81% and 52% in SRU 3 (P < .0001, both trends) and 82 (89.1%) fewer benign cysts would have gone directly to surgical evaluation. In multivariate regression, SRU rating predicted both any neoplasm (odds ratio, 2.58; P < .0001) and malignant neoplasm (odds ratio, 4.94; P = .005). Conclusion SRU consensus guidelines effectively stratified the risk of neoplasia and malignancy. Selecting MR imaging when it is an option in the guidelines would have reduced the number of benign cysts sent for surgical evaluation. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Maturen KE, Blaty AD, Wasnik AP, et al. Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound Guidelines. Radiology. 2017. PMID: 28727500. doi:10.1148/radiol.2017161625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。